Table 1.
SWAAC COVID-19 ECMO patients and centers characteristics
| Center’s characteristic | All patients (n = 307) | Established (n = 229) | New (n = 78) |
|---|---|---|---|
| Country, n (%) | |||
| Saudi Arabia | 125 (40.7) | 100 (43.6) | 25 (32) |
| Kuwait | 64 (20.9) | 14 (6) | 50 (64) |
| Qatar | 45 (14.7) | 54 (23.5) | 0 |
| India | 69 (22.5) | 66 (28.8) | 3 (3.8) |
| Egypt | 4 (1.3) | 4 | 0 |
| Number of Centers in each country | |||
| Saudi Arabia | 9 | 6 | 3 |
| Kuwait | 2 | 1 | 1 |
| Qatar | 3 | 3 | 0 |
| India | 4 | 3 | 1 |
| Egypt | 1 | 1 | 0 |
| Type of ECMO, n (%) | |||
| VV | 288 (93.5) | 217 (70.6) | 71 (23.1) |
| VA | 10 (3.3) | 10 (3.2) | 0 |
| VA-V | 9 (2.9) | 8 (2.6) | 1 (0.3) |
Data are median (IQR) unless specified otherwise. Established center: active ECMO program established before COVID-19 pandemic
SWAAC South Asia, West Asia, and Africa Chapter, ECMO extracorporeal membrane oxygenation, VV veno-venous, VA veno-arterial, VA-V veno-arterial venous